Taurine: Small Blood-Pressure Changes, Aging Claims, and Label Math

What is taurine?

Taurine is a sulfur-containing amino acid-like compound found throughout the body. The body makes it, and animal foods contain additional taurine. Supplements sell plain taurine in capsules and powder, while energy drinks and magnesium taurate put the name on very different products.

The clearest human findings concern blood pressure and vascular measurements: one trial studied mildly raised pressure, and a newer trial studied people with type 2 diabetes. Reviews also report small changes in blood sugar and blood fats. The anti-aging claim is weaker still—animal lifespan findings have not become evidence that taurine slows aging in people.

What taurine does in your body

Taurine is present largely as a free compound rather than being incorporated into proteins like the usual protein-building amino acids. Cells use it as part of the system that controls water balance and maintains a suitable internal environment.

In the liver, taurine is attached to bile acids, which help the digestive system handle fats. In muscle and other tissues, taurine also participates in regulation involving calcium, important for normal contraction and cellular signaling.

The body produces taurine and obtains more from food. ^[1]

The short version

Unit: milligrams (mg) or grams (g) of taurine; 1 g equals 1,000 mg.

Dose decision: neither the National Academies nor the National Institutes of Health has set a recommended daily amount or upper limit for taurine. There is no established wellness dose.

Typical listings: 500 mg or 1,000 mg capsules; some powder labels describe about 1 g per quarter teaspoon.

Skip: products that hide the taurine amount; you cannot compare them with the amounts used in trials.

What people take taurine for

About the evidence assessments: “Review pending” means we have not finished assessing the research; it describes our review status rather than an evidence-strength rating. The findings below separate published results and disagreements from checks we still need to complete.

Healthy adults do not have a diagnosed taurine requirement or routine taurine test. People who eat no animal foods get little from food, but the body still makes its own; that fact alone does not show a need for pills.

If a specialist has ordered an amino-acid blood panel, follow that laboratory’s preparation instructions. For its plasma panel^[2], ARUP prefers adults to fast; for infants and children, it specifies collection before feeding or two to three hours after a meal. It also asks for clinical information, including diet and medicines. These instructions do not specify a taurine-supplement stopping interval.

Trials suggest small reductions in blood pressure, blood sugar, and blood fats in some populations. Anyone taking blood-pressure or diabetes medicine should discuss taurine with the clinician monitoring those numbers. Pregnancy, breastfeeding, and routine use in children lack adequate supplement safety evidence.

What foods are high in taurine?

A food analysis^[3] reported the following broad patterns per 100 g. Food species, cuts and preparation matter, so these ranges are not label-like guarantees.

A vegan diet may supply very little taurine from food: this analysis detected none in its tested plant foods, while shellfish and meat supplied measurable amounts. Your body can also make taurine from other amino acids, so low food intake alone does not establish a deficiency or a need for a taurine supplement.

What to pay attention to on the label

Find the taurine amount per serving and confirm whether the product is plain taurine. A serving can contain several capsules, and a front-label capsule count does not reveal milligrams per capsule.

Magnesium taurate illustrates the hidden-amount problem. Chemistry can estimate taurine from a pure compound, but a label that declares 125 mg of magnesium does not verify the taurine amount or prove that the product is pure magnesium taurate. If the decision depends on taurine milligrams, use a product that states them directly.

An aging claim may be borrowed from the 2023 animal study. A blood-pressure claim may cite a pooled average without saying the trials measured readings rather than cardiovascular events.

Drawbacks and side effects

Safety details

No official upper limit exists. A 2008 review found strong safety evidence up to 3 g/day, while higher amounts had less evidence. If you take medicines that lower blood pressure or glucose, review taurine use and monitoring with the prescriber.

What the blood-pressure evidence shows

In a 2016 trial, 120 adults with mildly raised blood pressure were assigned to 1.6 g of taurine a day or placebo for 12 weeks. Ninety-seven completed the study. The authors’ main analysis included 104 people who took at least one dose and had at least one follow-up measurement, rather than everyone randomized; missing later measurements were replaced with the last available value. Office systolic pressure—the top number—fell 7.2 millimeters of mercury (mm Hg) with taurine and 2.6 mm Hg with placebo. Diastolic pressure, the bottom number, fell 4.7 versus 1.3 mm Hg. Around-the-clock systolic readings showed a smaller difference: about 3.8 versus 0.3 mm Hg.

Pooled analyses reported systolic differences of roughly 3–4.5 mm Hg. The diastolic estimates varied: the 2018 blood-pressure review^[4], with seven studies and 103 people, translated its result to about 3 mm Hg; the 2024 metabolic review^[5] reported about 1.5 mm Hg; and the 2026 review^[6], with 34 trials, reported about 2.5 mm Hg.

The 2024 metabolic review included 25 trials overall and the related 2024 cardiovascular review^[7] included 20. Their systolic estimates came from the same 12 study results, so they are not independent confirmations. They also disagree about the direction of one study’s diastolic result: for Spohr’s 2005 trial, the metabolic review prints slightly lower pressure with taurine, while the cardiovascular review prints slightly higher pressure. We have not yet checked the underlying blood-pressure data to resolve that disagreement. Both reviews also include an intravenous mixed-amino-acid treatment, so their averages do not isolate the effect of oral taurine. None of these pooled readings establishes prevention of heart attacks or strokes.

Office readings and blood pressure through the day

The 2016 numbers are changes within each group. Subtracting the placebo change gives an added clinic reduction of about 4.6 mm Hg systolic and 3.4 mm Hg diastolic. For the around-the-clock systolic recording, the corresponding difference was about 3.5 mm Hg. This matters because the headline 7.2-point fall includes improvement also seen in people receiving placebo. The clinic comparison favored taurine. Around-the-clock changes pointed in the same direction, but those readings came from only 86 participants, and the figures mainly mark changes from each group’s own starting value. They do not clearly show a statistical test of the difference between groups for those readings. Nighttime blood pressure did not significantly improve.

Taurine in type 2 diabetes

A 2025 trial^[8] studied 165 adults with type 2 diabetes, using 0.8 g of taurine three times daily or placebo for 12 weeks. Its main outcome was arterial stiffness, assessed from the speed of the pulse wave traveling between the arm and ankle. It also measured blood pressure and how well an artery widened, both in response to increased blood flow and to nitroglycerin, a drug that relaxes blood vessels.

The figures show favorable post-treatment comparisons for stiffness, both dilation tests and blood pressure. The widely quoted 7 mm Hg systolic reduction is the taurine group's change from its own starting value. That figure alone does not tell us how much more it improved than with placebo.

Complete measurements were available for 66 of 82 taurine participants and 78 of 83 placebo participants. That imbalance matters: more people were missing from the taurine result. The paper says its analysis accounted for participants according to their original treatment assignment, but its figures show only the groups with complete measurements. The trial adds a positive vascular finding in diabetes, with uncertainty about how missing follow-up affected it. Chinese public grants supported the study; the authors declared no competing interests.

Why heart-function claims need a closer look

The 2024 cardiovascular review reported improvements in heart pumping and heart-failure severity. The individual studies tell different stories.

An older trial^[9] assigned 78 people with diastolic heart failure and metabolic syndrome to usual treatment with or without 1 g/day of taurine for 12 months. The taurine group improved more in functional class—a rating of how much symptoms limit activity—and in ejection fraction, the percentage of blood the heart pumps out with each beat. This was taurine added to enalapril and indapamide, not a replacement for them. The original paper reported a clear improvement in functional class compared with usual treatment alone. The review’s calculated estimate did not show a statistically clear benefit; we have not yet resolved why the original report and the review’s calculation disagree. Some outcome counts also fall short of the 39 people assigned to each group.

Other positive findings came from mixtures. In 41 people with reduced pumping function awaiting bypass surgery^[10], the multi-nutrient product MyoVive reduced the volume of the heart’s main pumping chamber at the end of filling compared with placebo. Its ejection-fraction result was not clearly positive. Another trial^[11] studied 40 women with heart failure around childbirth, using intravenous Aminoven, a mixed amino-acid preparation, alongside standard care for five days. It reported a larger ejection-fraction improvement, but its tables and prose contain conflicting figures and symptom counts.

Small trials of oral taurine in heart failure

A 1985 crossover trial^[12] gave fourteen people with congestive heart failure either 6 g/day oral taurine in three divided doses or placebo for four weeks each. They continued fixed doses of digitalis, diuretics and/or vasodilators. The clinical activity-limitation class and some examination and chest-x-ray findings favored taurine. The study reported no side effects during taurine, but fourteen short exposures cannot establish long-term safety.

A six-week study in seventeen patients^[13] compared 3 g/day oral taurine with 30 mg/day coenzyme Q10. The authors reported improved systolic pumping measures in the taurine group; the abstract does not provide a precise between-group effect. These small studies make an oral-taurine signal worth distinguishing from the mixed-preparation review above. They do not establish fewer admissions or deaths, and their background treatment differs from present-day heart-failure care.

These findings warrant further investigation. Pooling oral taurine with multi-nutrient and intravenous treatments does not reveal how much benefit came from oral taurine itself.

Cramps and fatigue in cirrhosis

Cirrhosis^[14] is permanent scarring and damage to the liver.

A crossover trial^[15] enrolled 49 people with chronic liver disease and frequent muscle cramps; thirty completed it. Participants took taurine or placebo during four-week periods. The study tested more than one taurine amount; at 2 g/day, it reported a reduction in self-recorded cramp frequency, duration and severity compared with placebo. The frequency difference was about seven fewer cramps per fortnight. The substantial dropout limits confidence in how broadly the result applies.

A 2026 trial^[16] asked about fatigue instead. It randomized 220 people with decompensated cirrhosis^[17]—a stage with complications such as fluid buildup in the abdomen or internal bleeding—to 1 g/day taurine plus usual care or usual care alone for twelve weeks. Among 202 completers, fatigue improved in both groups without a clear added benefit from taurine. An analysis added after the main study plan suggested a benefit in patients without anemia^[18], a shortage of healthy red blood cells. That finding needs confirmation because the subgroup was small, the analysis was unplanned and treatment was not blinded. Cramp relief and general fatigue are different outcomes.

What the metabolic evidence shows

Across trials using different amounts and durations, the 2026 review’s abstract^[6] reported pooled mean differences favoring taurine: about 6 mg/dL for fasting blood sugar, 0.2 percentage points for HbA1c, 14 mg/dL for triglycerides, a type of blood fat, and 5 mg/dL for LDL cholesterol. Here mg/dL means milligrams per deciliter of blood. HbA1c reflects roughly three months of blood sugar. The abstract does not describe the control treatments or explain whether the calculation used final measurements or changes from starting levels. We have not yet checked those details in the full review, including which treatments and populations contributed to each result.

Does taurine slow aging?

Not shown in people. A 2023 paper reported that taurine fell with age in mice, monkeys, and humans and that supplementation extended mouse lifespan. Its larger human dataset linked blood taurine and related compounds with health measurements; it did not test supplements, and the associations were not uniformly favorable. The monkey experiment measured health changes over six months, not lifespan extension. The paper disclosed related Columbia University patent applications naming the lead investigator as an inventor.

Two 2025 studies challenged the human premise. One examined three human groups plus monkeys and mice and found taurine rose or stayed stable with age. Another, in 137 men aged 20 to 93, found no relation between taurine and age, muscle, or strength. Human blood levels are not lifespan trials either way; what remains open is whether supplementation affects aging outcomes in people.

Does taurine improve thinking?

A 2025 review of seven trials involving 402 people found no clear overall improvement in thinking scores. A subgroup receiving taurine alongside medicines improved on one cognitive test, but that result does not establish a benefit from taurine alone. ^[19]

Does taurine improve exercise performance?

A 2018 meta-analysis found a modest average improvement in endurance with isolated oral taurine, including on tests of how long participants could continue exercising before exhaustion. The included studies used 1–6 g, either once or for up to two weeks. They were small and varied in participants and tests. A later review also found mixed results across exercise outcomes. The positive endurance signal deserves further study, but the evidence does not establish a dependable workout dose or benefit for every kind of performance.

The bottom line

Taurine has useful blood-pressure findings and a newer positive vascular trial in type 2 diabetes, alongside modest changes in metabolic measurements. The much bigger claim—that taking it slows human aging—has not been established by those trials or by animal lifespan results.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly